These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23848400)

  • 1. Emerging drugs on methicillin-resistant Staphylococcus aureus.
    Liapikou A; Torres A
    Expert Opin Emerg Drugs; 2013 Sep; 18(3):291-305. PubMed ID: 23848400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
    Kollef MH
    Crit Care Resusc; 2009 Dec; 11(4):282-6. PubMed ID: 20001879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus therapy: past, present, and future.
    Rodvold KA; McConeghy KW
    Clin Infect Dis; 2014 Jan; 58 Suppl 1():S20-7. PubMed ID: 24343828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
    Stein GE; Wells EM
    Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of infections caused by resistant Staphylococcus aureus.
    Anstead GM; Quinones-Nazario G; Lewis JS
    Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternative agents to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Culos KA; Cannon JP; Grim SA
    Am J Ther; 2013; 20(2):200-12. PubMed ID: 21642833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of available and investigational antibiotics for complicated skin infections and treatment-resistant Staphylococcus aureus and enterococcus.
    Scheinfeld N
    J Drugs Dermatol; 2007 Jan; 6(1):97-103. PubMed ID: 17373167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatments for methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Corey GR
    Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empirical therapy in Methicillin-resistant Staphylococcus Aureus infections: An Up-To-Date approach.
    VanEperen AS; Segreti J
    J Infect Chemother; 2016 Jun; 22(6):351-9. PubMed ID: 27066882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options.
    Welte T; Pletz MW
    Int J Antimicrob Agents; 2010 Nov; 36(5):391-400. PubMed ID: 20724119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus: the superbug.
    Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of antibiotics for the treatment of MRSA complicated skin and soft tissue infections.
    Logman JF; Stephens J; Heeg B; Haider S; Cappelleri J; Nathwani D; Tice A; van Hout BA
    Curr Med Res Opin; 2010 Jul; 26(7):1565-78. PubMed ID: 20429820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marine bacteria: potential sources for compounds to overcome antibiotic resistance.
    Eom SH; Kim YM; Kim SK
    Appl Microbiol Biotechnol; 2013 Jun; 97(11):4763-73. PubMed ID: 23640363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options.
    Purrello SM; Garau J; Giamarellos E; Mazzei T; Pea F; Soriano A; Stefani S
    J Glob Antimicrob Resist; 2016 Dec; 7():178-186. PubMed ID: 27889013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
    Campbell ML; Marchaim D; Pogue JM; Sunkara B; Bheemreddy S; Bathina P; Pulluru H; Chugh N; Wilson MN; Moshos J; Ku K; Hayakawa K; Martin ET; Lephart PR; Rybak MJ; Kaye KS
    Ann Pharmacother; 2012 Dec; 46(12):1587-97. PubMed ID: 23212935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Guidelines for the treatment on infections caused by methicillin-resistant Staphylococcus aureus].
    Mensa J; Barberán J; Llinares P; Picazo J; Bouza E; Alvarez-Lerma F; Borges M; Serrano R; León C; Guirao X; Arias J; Carreras E; Sanz M; García-Rodríguez J; ; ; ; ; ;
    Rev Esp Quimioter; 2008 Dec; 21(4):234-58. PubMed ID: 19031124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.